Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06926816 · ClinicalTrials.gov registry record · NA

Universal Genetic Testing for Cancer Risk Reduction

A NA study of Genetic Testing, sponsored by NYU Langone Health.

Recruiting
Registry status
NA
Development phase
600
Enrollment target
1
Study location

NCT06926816 is a NA study of Genetic Testing that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 600 participants, roughly in line with the 561-participant average among 7 other Genetic Testing trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06926816, a NA study of Genetic Testing, is actively recruiting participants, sponsored by NYU Langone Health.

RECRUITING
Registry status
NA
Development phase
600 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to see if offering genetic testing for cancer-related genes is feasible and acceptable for patients presenting for gynecology clinic visits, instead of needing to see specialized providers or needing to meet specific criteria. The primary aim to assess the proportion of patients who undergo genetic testing, and the proportion of patients with pathogenic variants.

Conditions Studied

Genetic Testing

Interventions

  • GENETIC Natera® Empower™ hereditary cancer panel test
  • OTHER Specialist Referral

Study Locations (1)

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2025-03-04
Est. Completion 2027-12-31
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06926816

The ClinicalTrials.gov registry entry for NCT06926816 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 561-participant average among 7 other Genetic Testing trials with a reported enrollment target. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Genetic Testing appearing as the primary indexed condition, and to 2 interventions - of which Natera® Empower™ hereditary cancer panel test is the first listed.

NCT06926816 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06926816 about?

NCT06926816 is a clinical study titled "Universal Genetic Testing for Cancer Risk Reduction". The purpose of this research study is to see if offering genetic testing for cancer-related genes is feasible and acceptable for patients presenting for gynecology clinic visits, instead of needing to see specialized providers or needing to meet specific criteria. The primary aim to assess the propo...

What is the current status of trial NCT06926816?

This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2025-03-04. Estimated completion is 2027-12-31.

What conditions does trial NCT06926816 study?

This clinical trial studies the following conditions: Genetic Testing.

What interventions are being tested in trial NCT06926816?

The interventions under investigation include: Natera® Empower™ hereditary cancer panel test (GENETIC), Specialist Referral (OTHER).

Who is sponsoring clinical trial NCT06926816?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06926816 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Genetic Testing

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Genetic Testing

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.